New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. February is Heart Health Month, and news around ...
Even as investors, founders and shoppers alike pay close attention to better-for-you food innovation, the reality on shelves remains intense and uncertain. 2024 data shows that only about 29% of new ...
Not all cheap stocks are necessarily worth buying. In the case of these three stocks, however, their relatively low price ...
AT 15 stone but too nervous to step foot inside the gym, Tanisha Riddell knew she needed to take drastic action to get in ...
Concord’s Charlie Foster, 40, went to Northeastern University to study journalism. But a chance summer gig cooking for the Guinness family — yes, the European aristocrats — set him on a new path.
In Q4/25, Upstart (UPST) delivered 64% YoY revenue growth, increasing profitability, and strong guidance for 2026 through 2028. The company's machine learning lending model outpaces difficult macro ...
These are six shop bought foods I used to buy all the time but completely stopped. Some became too expensive, others just weren’t worth it anymore. Homemade versions win almost every time. Convenience ...
Confused about renting vs. buying? Tae Kim breaks down a 5-step framework to help you make the right financial decision. Learn to assess costs, timelines, and lifestyle factors. Democrats break with ...
As Hawaiʻi continues to pinch pennies and fill holes created by federal cuts, lawmakers may have to choose between bills ...
The rare disease drugmaker is facing potential competitors for achondroplasia drug Voxzogo. Is a big M&A deal with two approved assets enough to maintain investor interest?
Moderna is a well-known biotech company from its pandemic success. Here's what investors should know about its growth story now.
The City Council approved a proposal that gives CPD access to grant funding to buy new oral drug testing equipment. Here's what to know about the system.